ANI Pharmaceuticals, Inc. (BST:BSFA)

Germany flag Germany · Delayed Price · Currency is EUR
54.50
+1.50 (2.83%)
At close: Jul 3, 2025
-6.03%
Market Cap 1.11B
Revenue (ttm) 623.65M
Net Income (ttm) -20.75M
Shares Out n/a
EPS (ttm) -1.07
PE Ratio n/a
Forward PE 10.09
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 54.50
Previous Close 53.00
Day's Range 54.50 - 54.50
52-Week Range 47.80 - 63.50
Beta n/a
RSI 50.59
Earnings Date Aug 7, 2025

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group pu... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 897
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol BSFA
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.